Stockhead on MSN

Rhythm Biosciences enhances GeneType colorectal cancer test with clinical and lifestyle risk factors

Rhythm Biosciences has upgraded its geneType colorectal cancer test with additional lifestyle and clinical risk factors. ...

Enhanced Genetype colorectal cancer risk test released - supports earlier disease detection and ColoSTAT® targeting

Rhythm Biosciences Ltd ('RHY', the 'Company' or the 'Group') (ASX: RHY), a transformative, predictive cancer diagnostics ...
Frontiers

Current Trends in Clinical Management of Colorectal Cancer

Colorectal cancer (CRC) remains one of the most prevalent and lethal malignancies worldwide, representing a major challenge ...

Guardant Health’s Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for ...

Natera Presents Updated Analyses From ALTAIR Clinical Trial at ASCO GI

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that new data from the ALTAIR trial will be presented at the 2026 American Society of Clinical ...

VESA Releases DisplayPort Automotive Extension v1.1 Specification with Executable Emulator for Automotive Display Safety and Security

The Video Electronics Standards Association (VESA®) today announced the release of version 1.1 of its DisplayPort™ Automotive Extension (DP AE) specification—the first open industry standard for ...